Wakefield Asset Management Lllp Xencor Inc Transaction History

Wakefield Asset Management Lllp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$26.68 - $41.63 $523,114 - $816,239	-19,607 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$33.67 - $43.44 $5,353 - $6,906	159 Added 0.82%	19,607 $787,000
Q3 2021 Nov 12, 2021	SELL	$30.65 - $35.68 $12,382 - $14,414	-404 Reduced 2.04%	19,448 $635,000
Q2 2021 Aug 10, 2021	BUY	$34.33 - $44.68 $681,519 - $886,987	19,852 New	19,852 $685,000

215

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.49B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.